|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
+0.65% | -29.32% |
| 14/12/17 | Vernalis : AGM Statement | PU |
| 14/12/17 | Vernalis PLC: AGM Statement | MW |
| 13/12/17 | Vernalis : enters into research collaboration with Daiichi Sankyo | PU |
| 13/12/17 | Vernalis : + Daiichi Sankyo Enter Collaboration | MW |
| 06/12/17 | Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration | PU |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Davis
BRD | Director/Board Member | 65 | 05/12/2022 |
Octavio Espinoza
BRD | Director/Board Member | 56 | 01/11/2022 |
Andrew Reardon
BRD | Director/Board Member | 52 | 01/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.65% | - | - | 0 | |
| +1.09% | +5.26% | +4.44% | +26.03% | 51.61B | |
| -1.07% | +2.82% | +474.18% | +601.24% | 44.89B | |
| +1.47% | +9.79% | +40.15% | +21.21% | 42.77B | |
| +1.44% | +7.77% | +19.27% | +90.94% | 42.58B | |
| -0.93% | -4.33% | +17.87% | +51.96% | 31.82B | |
| +1.32% | +7.30% | +36.93% | +152.36% | 17.33B | |
| -0.60% | +1.93% | - | - | 16.63B | |
| +0.03% | +3.41% | +7.12% | +35.49% | 14.76B | |
| +1.28% | +5.41% | +91.01% | +46.93% | 14.09B | |
| Average | +0.40% | +4.43% | +86.37% | +128.27% | 30.72B | |
| Weighted average by Cap. | +0.49% | +4.72% | +102.57% | +148.52% |
- Stock Market
- Stocks
- VER Stock
Select your edition
All financial news and data tailored to specific country editions
